Mobile-health Network Solutions (MNDR) AI Stock Analysis
MNDR AI stock analysis summary
AI ResearchMobile-health Network Solutions (MNDR) is a Singapore-based provider of telehealth and primary healthcare services operating through its MaNaDr and MaNaCare platforms. In FY2025, revenue contracted 58.7% to $5.8M with net income of -$2.6M. The company maintains a net cash position of $2.6M with total debt of $95,666 as of December 31, 2025.
- Market cap
- $1.1M
- Revenue (TTM)
- $7.3M
- P/E
- —
- 1Y return
- -95.4% S&P 500 16.8%
- Avg. target
- $8.00 769.6% vs last close
Bull case
- The company maintains a solid balance sheet with $2.6M in net cash and minimal total debt of $95,666 as of December 31, 2025.
- Over a four-year period from FY2021 to FY2025, revenue grew at a CAGR of 31.7%.
- Wall Street analysts have a mean price target of $8.00, implying a 769.6% premium over the closing price of $0.92.
Bear case
- Revenue fell 58.7% in FY2025 to $5.8M, down sharply from $14.0M in FY2024.
- The company reported free cash flow of -$3.3M in FY2025 along with an operating margin of -46.4%.
- MNDR shares fell 95.4% over the past year, trading at $0.92 compared to a 52-week high of $32.52.
What Mobile-health Network Solutions does
Mobile-health Network Solutions is a Singapore-based investment holding company providing comprehensive telehealth solutions. It operates two core segments: Telemedicine and Other Services, and the Sale of Medicine and Medical Devices. Its flagship MaNaDr platform connects users to healthcare services, medical consultations, vaccinations, health screenings, geriatric care, and minor surgical procedures via mobile and web apps. The company also offers e-commerce wellness products, wholesale pharmaceuticals, and the MaNaCare corporate healthcare platform. Additionally, it develops IT systems, operates pharmacies and clinics, and provides beauty and personal care services.
Growth and profitability
Revenue expanded from $1.9M in FY2021 to a peak of $14.0M in FY2024 before dropping 58.7% to $5.8M in FY2025, reflecting a 4-year revenue CAGR of 31.7%. Gross margin deteriorated from 18.2% in FY2024 to -11.5% in FY2025, while operating margin sat at -46.4%. Net income was -$2.6M in FY2025, compared to -$15.6M in FY2024 and $92,697 in FY2022. For the trailing twelve months, revenue was $7.3M with an operating margin of -22.2% and a net profit margin of -35.3%. In the latest quarter ending December 31, 2025, quarterly revenue declined 7.7% year-over-year.
Balance sheet and cash flow
As of December 31, 2025, Mobile-health Network Solutions held $2.7M in cash and short-term investments against total debt of $95,666, yielding net cash of $2.6M. Liquidity is supported by a current ratio of 4.22 and a debt-to-equity ratio of 0.01. Operating cash flow in FY2025 was -$3.3M, and free cash flow stood at -$3.3M. The company allocated $47,661 to capital expenditures in FY2025, while its share count changed by -79.2% over 5 years.
Valuation and performance
At a market cap of $1.1M and an enterprise value of -$1.7M, Mobile-health Network Solutions trades at a price-to-sales multiple of 0.2x and a price-to-book ratio of 0.2x. In contrast, the median of its US-listed Healthcare peers trades at a price-to-sales multiple of 4.1x and an EV-to-EBITDA multiple of 12.0x. MNDR stock has dropped 95.4% over the past year and 82.8% year-to-date, closing at $0.92, while the S&P 500 (SPY) gained 16.8% over the same one-year span.
What analysts expect
Analysts set a mean price target of $8.00 for Mobile-health Network Solutions, indicating a 769.6% difference from the last close of $0.92. For the next fiscal year, the consensus revenue estimate is $0 with an expected revenue growth rate of 76.4%, while the EPS estimate is $0.00, reflecting projected EPS growth of 150.0%. The company is scheduled to report its next earnings on October 30, 2026.
Key risks and what to watch
- Quarterly revenue contracted 7.7% year-over-year in the period ending December 31, 2025.
- Gross margin turned negative at -11.5% in FY2025 after reaching 18.2% in FY2024.
- Trailing twelve months profit margin stands at -35.3%, resulting in an EPS of -$14.88.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this MNDR AI stock analysis
This page is an AI-written research summary of Mobile-health Network Solutions (MNDR). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: MNDR income statement, MNDR balance sheet, MNDR key metrics, MNDR chart. See the MNDR stock overview for the latest quote and news.
MNDR AI stock analysis FAQ
What is Mobile-health Network Solutions' core platform?
The company operates the MaNaDr platform, an ecosystem connecting users to telemedicine, general consultations, vaccinations, and health screenings. It also provides the MaNaCare platform for corporate healthcare services.
What are MNDR's cash and debt levels?
As of December 31, 2025, the company had $2.7M in cash and short-term investments and $95,666 in total debt, resulting in net cash of $2.6M.
How did MNDR perform financially in FY2025?
In FY2025, revenue declined 58.7% to $5.8M, generating net income of -$2.6M and free cash flow of -$3.3M.
What is the analyst price target for MNDR stock?
The mean analyst price target is $8.00, representing a 769.6% difference compared to the last close of $0.92.